{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-265256","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.837636+00:00","generated_at":"2026-06-09T07:15:00.965945+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Ginkgo Bioworks amends bylaws to tighten director nomination and stockholder proposal rules","bullets":["New requirement that nominating stockholders comply with Rule 14a-19 (universal proxy rules).","Expanded disclosures required from director nominees and nominating stockholders, including ownership and interests.","Nominees must use a proxy card color other than white for their solicitations.","Removed requirement to maintain a stockholder list at meetings, per updated Delaware law.","All amendments effective immediately as of October 27, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-265256","json":"https://secwatch.observer/filing/0001193125-23-265256.json","markdown":"https://secwatch.observer/filing/0001193125-23-265256.md","text":"https://secwatch.observer/filing/0001193125-23-265256.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000119312523265256/0001193125-23-265256-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000119312523265256/d563263d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T07:15:00.965945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"86860adfd56ad22bf9044fa189619d51d1e7fb60","claim":"Ginkgo Bioworks Holdings, Inc.: Board approved amendment and restatement of Bylaws, effective immediately, revising director nomination procedures, stockholder proposal requirements, disclosure obligations, proxy card color mandate, and removing stockholder list inspection requirement no longer required under DGCL (effective 2023-10-27).","evidence_excerpt":"On October 27, 2023, the board of directors (the “Board”) of Ginkgo Bioworks Holdings, Inc. (the “Company”) approved an amendment and restatement of the Company’s Bylaws (the “Amended and Restated Bylaws”), effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000119312523265256/0001193125-23-265256-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-10-27"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}